Skip to content

Community Cohort Study on the Influence of Traditional Chinese Medicine Intervention on Hypertension Progression

Community Cohort Study on the Influence of Traditional Chinese Medicine Intervention on Hypertension Progression

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006781
Enrollment
Unknown
Registered
2022-11-15
Start date
2021-12-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Control groups:CCB
Trial groups:song ling xue mai kang and CCB

Sponsors

The First Affiliated Hospital of Henan University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) Age = 18 years 2) Met the diagnostic criteria of hypertension, and the grading was classified as hypertension grade 1 or 2; 3) Signed informed consent.

Exclusion criteria

Exclusion criteria: 1) AMI, acute cerebral infarction, intracerebral hemorrhage, unstable angina; 2) Hypertension grade 3; secondary hypertension; 3) Patients with severe heart, liver and kidney, blood and nervous system diseases such as malignant tumors and renal failure, liver cirrhosis and severe heart failure were combined; 5) Were in pregnancy; 6) Associated with major depression, schizophrenia and other severe mental illnesses.

Design outcomes

Primary

MeasureTime frame
blood pressure;Target organ damage indicators;TCM syndrome;

Countries

China

Contacts

Public ContactDu tinhai
dth2010@163.com13503999897

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026